Anti-inflammatory medications, such as those commonly prescribed for arthritis, improve depressive symptoms in those with MDD.
A new study reveals minocycline, a popular antibiotic, can help extend lifespan and improve protein balance in aging worms. Researchers say the protective mechanism of the medication could be exploited to help prevent neurodegenerative diseases like Alzheimer's or Parkinson's in humans.
Minocycline, a broad-spectrum tetracycline antibiotic, has shown promise in the treatment of depression. Researchers say the antibiotic could help reduce brain inflammation associated with some cases of major depressive disorder. A small study conducted by researchers at Deakin University found those treated with Minocycline reported improved quality of life, reduced anxiety symptoms and a better global impression of their depression.
A new study backs up previous research regarding the effectiveness of ketamine in treating depression. Additionally, researchers identified antidepressant effects in Botox, Diclofenac and Minocycline, drugs commonly used for other purposes.
A new study reports that when minocycline is given to new born rats following a head injury, cognitive deficits are exacerbated.
